时机决定一切:长骨骨折合并主要动脉损伤对预后的影响
PRE组血管相关并发症更多(58% vs 32%,p=0.03),包括横纹肌溶解(42% vs 19%)、移植物失败(26% vs 8%)和截肢(37% vs 13%);死亡率无差异(0% vs 2%)。多因素分析显示PRE是移植物失败(OR 3.98,95%CI 1.11-14.33)和截肢(OR 3.924,95%CI 1.272-12.111)的唯一独立预测因素。结论推荐延迟骨折固定至血管重建后。
要点
- 同一肢体长骨骨折合并主要动脉损伤需手术修复者,血管重建前骨折固定组血管相关并发症58% vs 血管重建后固定组32%(p=0.03)。
- 血管重建前骨折固定组移植物失败26% vs 8%(p=0.026),截肢37% vs 13%(p=0.013),横纹肌溶解42% vs 19%(p=0.029)。
- 多因素分析:血管重建前骨折固定是移植物失败(OR 3.98,95%CI 1.11-14.33)和截肢(OR 3.924,95%CI 1.272-12.111)的唯一独立预测因素。
- 两组死亡率无差异(0% vs 2%,p>0.99),但PRE组穿透伤比例更低(32% vs 60%)、血管重建时间更长(9.5 vs 5.8小时)。
- 推荐对此类患者延迟临时或最终骨折固定至血管重建后,以降低血管相关并发症。
适用人群与场景
- 纳入标准:同一肢体的长骨骨折合并主要动脉损伤需手术修复。
- 排除标准原文未提及。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 第一步:对同一肢体长骨骨折合并主要动脉损伤需手术修复的患者,优先行血管重建。
- 第二步:延迟临时或最终骨折固定至血管重建后(POST策略),原文结论推荐此为首选方法。
- 原文未提及具体药物剂量、给药途径、频次或目标值。
红旗征与不能漏的情况
- 血管重建前进行骨折固定与更高的血管相关并发症相关:横纹肌溶解42% vs 19%、移植物失败26% vs 8%、截肢37% vs 13%。
- 血管重建前骨折固定是移植物失败(OR 3.98)和截肢(OR 3.924)的唯一独立预测因素,应避免此顺序。
研究设计与关键结果
- 分组:血管重建前骨折固定组(PRE)19例 vs 血管重建后骨折固定组(POST)85例。
- 两组年龄、性别、损伤严重度评分、入院碱剩余、24小时浓缩红细胞用量、合并静脉损伤相似;PRE组穿透伤比例更低(32% vs 60%,p=0.024),血管重建时间更长(9.5 vs 5.8小时,p=0.0002)。
- 主要结果:PRE组血管相关并发症更多(58% vs 32%,p=0.03),包括横纹肌溶解(42% vs 19%,p=0.029)、移植物失败(26% vs 8%,p=0.026)、截肢(37% vs 13%,p=0.013);死亡率无差异(0% vs 2%,p>0.99)。
- 多因素logistic回归:PRE是移植物失败(OR 3.98,95%CI 1.11-14.33,p=0.03)和截肢(OR 3.924,95%CI 1.272-12.111,p=0.017)的唯一独立预测因素。
证据类型、等级与局限
- 证据类型:回顾性预后研究,证据等级Level IV。
对床旁实践的改变
- 对同一肢体长骨骨折合并主要动脉损伤需手术修复的患者,应优先血管重建、延迟骨折固定,以降低移植物失败和截肢风险。
- 避免在血管重建前进行临时或最终骨折固定,因其与更高的血管相关并发症相关。
- 原文未提及适用与不适用人群的进一步限定或常见陷阱。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Timing of extremity fracture fixation in patients with an associated major vascular injury remains controversial. Some favor temporary fracture fixation before definitive vascular repair to limit potential graft complications. Others advocate immediate revascularization to minimize ischemic time. The purpose of this study was to evaluate the timing of fracture fixation on outcomes in patients with concomitant long bone fracture and major arterial injury.
METHODS: Patients with a combined long bone fracture and major arterial injury in the same extremity requiring operative repair over 11 years were identified and stratified by timing of fracture fixation. Vascular-related morbidity (rhabdomyolysis, acute kidney injury, graft failure, extremity amputation) and mortality were compared between patients who underwent fracture fixation prerevascularization (PRE) or postrevascularization (POST).
RESULTS: One hundred four patients were identified: 19 PRE and 85 POST. Both groups were similar with respect to age, sex, Injury Severity Score, admission base excess, 24-hour packed red blood cells, and concomitant venous injury. The PRE group had fewer penetrating injuries (32% vs. 60%, p = 0.024) and a longer time to revascularization (9.5 vs. 5.8 hours, p = 0.0002). Although there was no difference in mortality (0% vs. 2%, p > 0.99), there were more vascular-related complications in the PRE group (58% vs. 32%, p = 0.03): specifically, rhabdomyolysis (42% vs. 19%, p = 0.029), graft failure (26% vs. 8%, p = 0.026), and extremity amputation (37% vs. 13%, p = 0.013). Multivariable logistic regression identified fracture fixation PRE as the only independent predictor of graft failure (odds ratio, 3.98; 95% confidence interval, 1.11-14.33; p = 0.03) and extremity amputation (odds ratio, 3.924; 95% confidence interval, 1.272-12.111; p = 0.017).
CONCLUSION: Fracture fixation before revascularization contributes to increased vascular-related morbidity and was consistently identified as the only modifiable risk factor for both graft failure and extremity amputation in patients with a combined long bone fracture and major arterial injury. For these patients, delaying temporary or definitive fracture fixation until POST should be the preferred approach.
LEVEL OF EVIDENCE: Prognostic study, Level IV.
参考来源
- Lewis RH, Perkins M, Fischer PE, et al. Timing is everything: Impact of combined long bone fracture and major arterial injury on outcomes. J Trauma Acute Care Surg. 2022. PMID: 34670960. doi:10.1097/TA.0000000000003430
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。